PRE-SEED CAPITAL FOR EMERGING COMPANIES

Imbolc Partners I

Novel therapeutics for Crohn's Disease and related auto-immune disorders
Building the definitive data platform
for environmental, health & safety tracking
Using quantum electrochemistry to
advance drug discovery
Personalized health care concierge to simplify benefits and boost productivity
Satellite-powered parametric climate insurance
for farmers, ranchers and fishermen
Smart electrocautery device with
integrated smoke evacuation
AI-enabled product lifecycle management and design platform for growing brand teams
Premium recovery drinks and energy pouches
celebrating the Underdog spirit
AI-driven commission management and compliance solutions for brokers

Imbolc Angel Fund

Digital platform for wise-use CBD products in palliative care settings
Celiac-friendly retailer serving New York and Los Angeles and expanding to Denver
AI-driven safety platform for real-time
consumption tracking
AI-enabled logistics and warehouse
management tools
Dose-adjustable gene therapy platform targeting metabolic health and longevity
Mobile health engagement platform (acquired Decision Point Healthcare)
Regional records management firm —
Imbolc's founding investment, exited with 9x return

About Imbolc Partners

  • Imbolc Partners began with the acquisition of Minuteman Archives, a small regional records management business, which was sold into a PE-backed industry roll-up for a 9x return. Building on that success, the firm operated as an angel group for a decade before launching Imbolc Partners I in 2024.
  • We write $100,000 checks and are often the first money in. We look where other VCs aren't: smaller deals, niche markets, and capital-efficient companies with a clear path to revenue and strong M&A potential. We move fast, with limited bureaucracy and a 30% principal commitment.
Contact: matt@imbolcpartners.com